Divergent Roles of α5 and β4 Nicotinic Receptor Subunits in Food Reward and Nicotine-induced Weight Loss in Male Mice.
Alberte Wollesen BreumSarah FalkCharlotte Sashi Aier SvendsenTrine Sand NicolaisenCecilie Vad MathiesenUwe MaskosChristoffer ClemmensenPublished in: Endocrinology (2022)
A major obstacle to successful smoking cessation is the prospect of weight gain. Despite a clear relationship between cigarette smoking and body weight, surprisingly little is known about the physiological and molecular mechanism by which nicotine affects energy homeostasis and food-motivated behaviors. Here we use loss-of-function mouse models to demonstrate that 2 nicotinic acetylcholine receptor (nAChR) subunits encoded by the CHRNA5-CHRNA3-CHRNB4 gene cluster, α5 and β4, exhibit divergent roles in food reward. We also reveal that β4-containing nAChRs are essential for the weight-lowering effects of nicotine in diet-induced obese mice. Finally, our data support the notion of crosstalk between incretin biology and nAChR signaling, as we demonstrate that the glycemic benefits of glucagon-like peptide-1 receptor activation partially relies on β4-containing nAChRs. Together, these data encourage further research into the role of cholinergic neurotransmission in regulating food reward and the translational pursuit of site-directed targeting of β4-containing nAChRs for treatment of metabolic disease.
Keyphrases
- smoking cessation
- weight gain
- weight loss
- body weight
- replacement therapy
- body mass index
- human health
- bariatric surgery
- electronic health record
- birth weight
- mouse model
- physical activity
- copy number
- cancer therapy
- dna methylation
- gene expression
- drug induced
- glycemic control
- oxidative stress
- climate change
- endothelial cells